Suchergebnisse - "Dogu, Mehmet Hilmi"

PubPharm (82)

1

Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients : a multicenter experience in Turkey

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Bakırtaş, M. | Dal, M. | Yiğenoğlu, T. | +17

2

Gilteritinib (XOSPATA®) in Turkey : Early Access Program Results

enthalten in: Mediterranean journal of hematology and infectious diseases | 2023

von Dogu, M. | Tekgunduz, A. | Deveci, B. | +5

3

Efficacy of the lactate dehydrogenase (LDH)/lymphocyte ratio (LLR) to reduce the need for X-ray in pregnant patients with COVID-19

enthalten in: Journal of perinatal medicine | 2022

von Dogu, S. | Serin, I. | Dogu, M. | +2

4

Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas : A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2022

von Kayıkçı, �. | Mehtap, �. | Sarı, �. | +16

5

Efficacy of the lactate dehydrogenase (LDH)/lymphocyte ratio (LLR) to reduce the need for X-ray in pregnant patients with COVID-19

enthalten in: Journal of perinatal medicine | 2022

von Dogu, S. | Serin, I. | Dogu, M. | +2

6

Efficacy of the lactate dehydrogenase (LDH)/lymphocyte ratio (LLR) to reduce the need for X-ray in pregnant patients with COVID-19

enthalten in: Journal of perinatal medicine | 2022

von Dogu, S. | Serin, I. | Dogu, M. | +2

7

The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

enthalten in: Clinical lymphoma, myeloma & leukemia | 2022

von Akpinar, S. | Dogu, M. | Celik, S. | +23

8

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

enthalten in: Internal and emergency medicine | 2022

von Başcı, S. | Ata, N. | Altuntaş, F. | +15

9

The use of hypomethylating agents in hematologic malignancies : treatment preferences and results

enthalten in: International journal of hematologic oncology | 2021

von Serin, I. | Dogu, M.

10

Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia : Retrospective Analysis of Real-Life Data

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2021

von Tombak, A. | Pepedil Tanrıkulu, F. | Durusoy, S. | +42

1
2
3
4
5
6
7
8
9
Nächster »
[9]